| Members |
targetComponentId |
| Amegakaryocytic thrombocytopenia with congenital malformation |
Thrombocytopenic purpura |
| Amegakaryocytic thrombocytopenia with congenital malformation |
Amegakaryocytic thrombocytopenia with congenital malformation |
| Amelia of lower limb |
Transverse deficiency lower limb - hip level |
| Amelia of lower limb |
Congenital complete absence of lower limb |
| Amelia of lower limb |
Intrauterine amputation of lower limb |
| Amelia of upper limb |
Congenital amputation of upper limb |
| Amelia of upper limb |
Congenital absence of upper limb |
| Amelia of upper limb |
Congenital complete absence of upper limb |
| American Samoan island |
Island in region of American Samoa |
| American Samoan island |
American Samoa |
| American avocet |
Recurvirostra americana (organism) |
| American beech pollen allergen |
American beech pollen |
| American black skimmer |
Rynchops niger (organism) |
| American cutaneous leishmaniasis (& [Chiclero ulcer]) |
Infection by Leishmania mexicana |
| American oyster-catcher |
Haematopus palliatus (organism) |
| Amethyst starling |
Cinnyricinclus leucogaster |
| Amidostomum species |
Amidostomum |
| amikacin 100 mg/2 ml injektionsvæske til børn |
Product containing precisely amikacin (as amikacin sulfate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| amikacin 250 mg/ml injektionsvæske, opløsning, hætteglas |
Product containing precisely amikacin (as amikacin sulfate) 250 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| amikacinsulfat 100 mg/2 ml pulver |
Product containing precisely amikacin (as amikacin sulfate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| bivirkning af amilorid og loop-diuretikum |
Loop diuretic adverse reaction |
| bivirkning af amilorid og loop-diuretikum |
Amiloride adverse reaction |
| bivirkning af diuretikum indeholdende amilorid og thiazid |
Amiloride adverse reaction |
| bivirkning af diuretikum indeholdende amilorid og thiazid |
Thiazide diuretic adverse reaction |
| amiloridhydrochlorid 5 mg/5 ml sukkerfri oral opløsning |
Product containing precisely amiloride hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Aminoacyl-histidine dipeptidase deficiency |
Carnosinuria (disorder) |
| Aminoacyl-histidine dipeptidase deficiency |
Carnosinemia (disorder) |
| Aminoacyl-histidine dipeptidase deficiency |
Carnosinuria (disorder) |
| Aminoacyl-histidine dipeptidase deficiency |
Carnosinemia (disorder) |
| Aminoacyl-histidine dipeptidase deficiency |
Hyper-beta-carnosinaemia |
| Aminoacyl-histidine dipeptidase deficiency |
Deficiency of aminoacyl-histidine dipeptidase |
| Aminoacyl-histidine dipeptidase deficiency |
Deficiency of aminoacyl-histidine dipeptidase |
| Aminobacter-art |
Aminobacter |
| forgiftning med aminoglycosider |
Poisoning caused by antibacterial aminoglycoside (disorder) |
| aminosalicylsyre |
Para-aminosalicylic acid |
| aminosalicylsyre |
Para-aminosalicylate |
| amiodaronhydrochlorid 30 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 10 ml |
Amiodarone hydrochloride 30 mg/mL solution for injection |
| amiodaronhydrochlorid 50 mg/ml koncentrat til infusionsvæske, 3 ml ampul |
Product containing precisely amiodarone hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| amiodaronhydrochlorid 50 mg/ml opløsning |
Product containing precisely amiodarone hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Amisulpride 100mg/mL s/f oral solution |
Amisulpride 100 mg/mL oral solution |
| amisulprid 100 mg/ml sukkerfri oral opløsning |
Amisulpride 100 mg/mL oral solution |
| amitriptylin 25 mg/5 ml sukkerfri oral opløsning |
Product containing precisely amitriptyline hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
| amitriptylin 50 mg/5 ml sukkerfri oral opløsning |
Product containing precisely amitriptyline hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
| amitriptylinhydrochlorid 25 mg kapsel med modificeret udløsning |
Amitriptyline hydrochloride 25 mg prolonged-release oral capsule |
| amitriptylinhydrochlorid 50 mg kapsel med modificeret udløsning |
Amitriptyline hydrochloride 50 mg prolonged-release oral capsule |
| amniocentese med komplikation, uden skyld |
Amniocentesis |
| Amniocentesis: [diagnostic] or [NEC] |
Diagnostic amniocentesis |
| Amniotic cavity infection (& [membranitis] or [placentitis]) |
Infection of amniotic cavity |
| Amniotic fluid analysis for erythroblastosis fetalis |
Amniotic fluid analysis for erythroblastosis fetalis |
| Amniotic fluid analysis for erythroblastosis fetalis |
Amniotic fluid analysis for hemolytic disease of the newborn |
| Amnionvæskeemboli efter graviditet med abort som udfald |
Induced termination of pregnancy complicated by amniotic fluid embolism (disorder) |
| amnionvæskeemboli efter molagraviditet OG/ELLER ektopisk graviditet |
Amniotic fluid embolism due to and following ectopic pregnancy (disorder) |
| amnionvæskeemboli efter molagraviditet OG/ELLER ektopisk graviditet |
Amniotic fluid embolism due to and following molar pregnancy |
| Amniotic fluid pulmonary surfactant test |
Pulmonary surfactant test |
| Amniotic fluid pulmonary surfactant test |
Amniotic fluid pulmonary surfactant test |
| Amniotic fluid pulmonary surfactant test |
Foam stability test |
| Amniotic fluid pulmonary surfactant test |
Shake test |
| Amniotic fluid sample |
Amniotic fluid specimen |
| Amniotic fluid sample |
Amniocentesis fluid specimen (specimen) |
| Amniotic fluid: [L/S ratio] or [lecithin] or [sphingomyelin] |
Lecithin detected in amniotic fluid |
| Amniotic fluid: [L/S ratio] or [lecithin] or [sphingomyelin] |
Sphingomyelin detected in amniotic fluid |
| Amniotic fluid: [L/S ratio] or [lecithin] or [sphingomyelin] |
Lecithin detected in amniotic fluid |
| Amniotic fluid: [L/S ratio] or [lecithin] or [sphingomyelin] |
Sphingomyelin detected in amniotic fluid |
| Amniotic membrane perforator, reusable |
Amnihook, device (physical object) |
| Amniotic membrane perforator, single-use |
Amnihook, device (physical object) |
| Amniotome, reusable |
Amnihook, device (physical object) |
| Amniotome, single-use |
Amnihook, device (physical object) |
| Amniotomy at delivery |
Induction of labor by artificial rupture of membranes (procedure) |
| Amniotomy at delivery |
Artificial rupture of membranes (procedure) |
| Amniotomy at delivery |
Amniotomy at delivery (procedure) |
| Amniotomy by nurse |
Artificial rupture of membranes (procedure) |
| Amniotomy by nurse |
Induction of labor by artificial rupture of membranes (procedure) |
| Amniotomy by nurse |
Amniotomy at delivery (procedure) |
| Amniotomy to induce labor |
Sweeping of membrane |
| Amniotomy to induce labor |
Amniotomy at delivery (procedure) |
| Amniotomy to induce labor |
Artificial rupture of membranes (procedure) |
| Amniotomy to induce labor |
Surgical induction of labor |
| Amniotomy to induce labor |
Induction of labor by artificial rupture of membranes (procedure) |
| amøbeart |
Amoeba |
| Amoebiasis |
Amebic dysentery (disorder) |
| Amoebiasis |
Infection caused by Entamoeba histolytica |
| Amoebiasis |
Amebic infection |
| Amoebiasis affecting skin |
Amoebiasis of skin |
| Amoebiasis affecting skin |
Amebic ulcer of skin (disorder) |
| bivirkning af amoxicillin + clavulanatkalium |
Adverse reaction to amoxicillin and/or clavulanic acid |
| Amoxicillin and clavulanate |
Product containing amoxicillin and clavulanic acid (medicinal product) |
| Amphetamin |
Chemical racemic free base or equal parts of enantiomers levoamphetamine and dextroamphetamine in their pure amine or salt forms. |
| Amphetamine and cocaine |
Product containing cocaine (medicinal product) |
| Amphetamine and cocaine |
Product containing amfetamine (medicinal product) |
| amfetamin eller psykostimulerende middel |
Psychostimulant (substance) |
| amfetamin eller psykostimulerende middel |
Amfetamine and/or amfetamine derivative |
| overdosis af amphetamin |
Amfetamine and/or amfetamine derivative overdose (disorder) |
| forgiftning med amphetamin, uvist med hvilken hensigt |
Poisoning caused by amfetamine and/or amfetamine derivative |
| Amphotericin (lipid formulation) 50mg powder for infusion solution vial |
Amphotericin B liposome 50 mg powder for solution for injection vial |
| amphotericin 100 mg pulver til infusionsvæske, opløsning, hætteglas |
Amphotericin B only product in parenteral dose form |
| amphotericin 100 mg/ml sukkerfri suspension |
Product containing precisely amphotericin B 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Amphotericin 5mg/mL conventional release suspension for injection 20mL vial |
Amphotericin B only product in parenteral dose form |
| amphotericin 5 mg/ml koncentrat til infusionsvæske, hætteglas a 20 ml |
Amphotericin B only product in parenteral dose form |
| bivirkning af ampicillin + flucloxacillin |
Adverse reaction to ampicillin and/or flucloxacillin (disorder) |
| bivirkning af ampicillin og cloxacillin |
Adverse reaction to ampicillin and/or cloxacillin |
| Ampicillin and sulbactam |
Product containing ampicillin and sulbactam (medicinal product) |
FHIR